Program

 Program at a glance

 Program
Friday, October 14  Program
Saturday, October 15  Program
Sunday, October 16

To read the PDF file you will need Adobe Reader installed on your computer.

Presidential Lecture

Friday, October 14　13:55-14:25　No.1 Fukuoka International Congress Center 3F Main Hall

Molecular target therapies to eradicate human leukemic stem cells

Chair：

Mine Harada (Medical Center for Karatsu-Higashimatsuura Medical Association)

Speaker：

Koichi Akashi (Professor,Department of Medicine and Biosystemic Science, Faculty of Medicine, Kyushu University)

JSH Award Lecture

Sunday, October 16　11:20-12:00　No.2 Fukuoka International Congress Center 2F 203・204

Confront with GVHD for 30 years

Chair：

Itaru Matsumura (Department of Hematology and Rheumatology、Kindai University Faculty of Medicine)

Speaker：

Teshima Takanori (Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan)

Plenary Session

Saturday, October 15　13:10-14:40　No.1 Fukuoka International Congress Center 3F Main Hall

Chair：

Akifumi Takaori-Kondo (Graduate School of Medicine, Kyoto University)
Takanori Teshima (Hokkaido University)

MLKL mediates age-related attrition of hematopoietic stem cells and ineffective hematopoiesis

Speaker：

Yuta  Yamada (The Institute of Medical Science, The University of Tokyo)

Apolipoprotein E mediates responses hematopoietic stem cells upon acute anemia induction

Speaker：

Kiyoka  Saito (International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan，Lund Stem Cell Center, Lund University, Lund, Sweden)

EVI1 promotes immune-evasive microenvironment via cyclin D1 in acute myeloid leukemia

Speaker：

Yosuke  Masamoto (Department of Hematology & Oncology, The University of Tokyo Hospital)

Multi-omics analysis defines novel molecular classification of infant acute lymphoblastic leukemia

Speaker：

Tomoya Isobe (Department of Pediatrics, University of Tokyo, Division of Molecular Oncology, University of Tokyo, Department of Hematology, University of Cambridge, Cambridge, UK)

GVHD targets organoid-forming biliary epithelial stem cells via a TGF-β-dependent manner

Speaker：

Yuta  Hasegawa (Department of Hematology, Hokkaido University Faculty of Medicine)

HLA-B supertype mismatch is associated with a higher rate of relapse in cord blood transplantation

Speaker：

Takeshi  Sugio (Kyushu University Department of Medicine and Biosystemic Science)

Special Lecture

Friday, October 14　14:30-15:10　No.1 Fukuoka International Congress Center 3F Main Hall

Normal and Neoplastic Stem Cells

Chair：

Koichi Akashi (Professor,Department of Medicine and Biosystemic Science, Faculty of Medicine, Kyushu University)

Speaker：

Irving Weissman (Institute for Stem Cell Biology and Regenerative Medicine / Stanford Ludwig Center for Cancer Stem Cell Research and Medicine, USA)

ASH Special Lecture

Friday, October 14　11:20-11:50　No.1 Fukuoka International Congress Center 3F Main Hall

Diffuse Large B-cell Lymphoma: 2022 Update

Chair：

Itaru Matsumura (Department of Hematology and Rheumatology、Kindai University Faculty of Medicine)

Speaker：

Jane N. Winter (Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, USA)

EHA Special Lecture

Saturday, October 15　17:20-17:50　No.1 Fukuoka International Congress Center 3F Main Hall

Challenges in the Diagnosis and Treatment of Chronic Myelomonocytic Leukemia

Chair：

Kinuko Mitani (Dokkyo Medical University)

Speaker：

Antonio Almeida (Hospital da Luz Lisboa Católica Medical School, Portugal)

Special Symposium

Part1　Frontier of clinical sequencing

Saturday, October 15　9:00-10:20　No.1 Fukuoka International Congress Center 3F Main Hall

Chair：

Mamiko Sakata-Yanagimoto (University of Tsukuba)
Takahiro Maeda (Division of Precision Medicine, Kyushu University Graduate School of Medical Sciences)

Utility of Whole Genome Sequencing in Clinical Profiling of Pediatric Cancer

Speaker：

Jinghui Zhang (St Jude Children's Research Hospital, USA)

Molecular Profiling of Lymphomas Using Circulating Tumor DNA

Speaker：

Ash A. Alizadeh (Moghadam Family Professor of Medicine Divisions of Oncology & Hematology Stanford Cancer Institute, USA)

Part2　Applying genomic profiling results to clinical practice: case studies

Saturday, October 15　10:20-11:40　No.1 Fukuoka International Congress Center 3F Main Hall

Asian Joint Panel Discussion

Friday, October 14　15:20-17:20　No.8 Fukuoka International Congress Center 5F 501

Recent progresses of molecular targeting therapy: how has it changed AML therapy in Asia?

Chair：

Yoshinobu Maeda (Okayama University Hospital)
Sampath Venkata Sreekanth (The Department of Haematology, Tan Tock Seng Hospital, Singapore)

Current status of acute promyelocytic leukemia in China.

Speaker：

Suning Chen (Jiangsu Institute of Hematology. The First afffiliated hospital of Soochow Unviersity, China)

Current status, challenges and clinical relevance of targeted therapy in Taiwan AML patients

Speaker：

Hsin-An Hou (Internal Medicine （Division of Hematology） , National Taiwan University Hospital, Taiwan)

Molecular target for FLT3-mutated AML: Data from Thai Acute Leukemia Working Group

Speaker：

Adisak Tantiworawit (Internal Medicine, ChiangMai University, Thailand)

Molecular targeting therapy for AML in Korea

Speaker：

Dong YeopShin (Internal Medicine, Seoul National University Hospital, Korea)

Promise and challenges with targeted therapy in AML: a perspective from India

Speaker：

Vikram Mathews (Dept of Haematology, Christian Medical College, India)

How I Use Venetoclax in Acute Myeloid Leukemia

Speaker：

Sampath Venkata Sreekanth (The Department of Haematology, Tan Tock Seng Hospital, Singapore)

Current Status of Molecular Targeted Therapy for AML in Japan

Speaker：

Yuichi Ishikawa (Department of Hematology, Nagoya University Hospital)

Symposium

Symposium1

Recent advances in leukemia stem cell research

Friday, October 14　9:00-11:00　No.1 Fukuoka International Congress Center 3F Main Hall

Chair：

Hideaki Nakajima (Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine)
Hideyo Hirai (Tokyo University of Pharmacy and Life Sciences, Laboratory of Stem Cell Regulation )

Mutation mechanisms in clonal hematopoiesis

Speaker：

Liran Shlush (Weizmann institute of science, Israel)

Analysis of mosaic chromosomal alteration in BioBank Japan

Speaker：

Yoichiro Kamatani (Graduate School of Frontier Sciences, the University of Tokyo)

Somatic evolutionin normal and neoplastic hematopoiesis through the lens of single-cell multi-omics

Speaker：

Dan Landau (WCM/NYGC, USA)

Chromatin accessibility in MDS stem and progenitor cells

Speaker：

Atsushi Iwama (Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo)

Genetic and Non-Genetic Determinants of Disease Progression in Myeloproliferative Neoplasms

Speaker：

Adam J Mead (University of Oxford, UK)

Symposium2

Dysregulation of erythropoiesis and associated diseases

Friday, October 14　9:00-11:00　No.2 Fukuoka International Congress Center 2F 203・204

Chair：

Naoshi Obara (University of Tsukuba)
Hiroshi Kawabata (Department of Hematology, National Hospital Organization Kyoto Medical Center)

Regulation of Megakaryocytic-Erythroid Progenitor Fate Specification

Speaker：

Diane Krause (Yale University, USA)

Integration of erythroid differentiation and autophagy by iron-heme metabolism

Speaker：

Kazuhiko Igarashi (Department of Biochemistry, Tohoku University Graduate School of Medicine)

Novel mechanisms of ineffective erythropoiesis in β-thalassemia

Speaker：

Yelena Ginzburg (Icahn School of Medicine at Mount Sinai, USA)

Molecular mechanisms of acquired pure red cell aplasia

Speaker：

Fumihiro Ishida (Department of Biomedical Laboratory Sciences, Shinshu University)

Symposium3

Cutting edge science in hematology 2022

Friday, October 14　15:20-17:20　No.1 Fukuoka International Congress Center 3F Main Hall

Chair：

Motohiro Kato (The University of Tokyo)
Atsushi Manabe (Department of Pediatrics, Hokkaido University Graduate School of Medicine)

Clinical characteristics and outcomes of childhood B-ALL with ZNF384 rearrangement and MEF2D rearrangement

Speaker：

Shinsuke Hirabayashi (Department of Pediatrics, Hokkaido University Hospital)

A developmental switch between pre-T-cell receptor signaling and BCL2 activity in T-cell acute lymphoblastic leukemia

Speaker：

Yoshihiro Gocho (National Center for Child Health and Development)

Fanconi anemia and Aldehyde Degradation Deficiency (ADD) Syndrome: DNA repair and metabolism together protect the genome and hematopoiesis

Speaker：

Minoru Takata (Radiation Biology Center, Graduate School of Biostdies, Kyoto University)

Aberrant RNA splicing in hematologic malignancies

Speaker：

Akihide Yoshimi (Cancer RNA Research Unit, National Cancer Center Research Institute)

Pharmacogenomic Landscape of Acute Lymphoblastic Leukemia

Speaker：

Jun J Yang (St. Jude Children’s Research Hospital, USA)

Symposium4

Recent advance in pathogenesis and treatment for thrombotic disorders

Saturday, October 15　9:00-11:00　No.2 Fukuoka International Congress Center 2F 203・204

Chair：

Takayuki Ikezoe (Fukushima Medical University)
Eriko Morishita (Department of Clinical Laboratory Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Faculty of Health Sciences, Kanazawa University)

Elucidation of anticoagulant function of FV abnormality and development of an easy-to-use screening assay associated with thrombophilia

Speaker：

Keiji Nogami (Department of Pediatrics, Nara Medical Univeristy)

COVID Associated Thrombosis—What We Know in 2022

Speaker：

Jean Marie Connors (Harvard Medical School Brigham and Women's Hospital Dana-Farber Cancer Institute, USA)

Recent considerations of the pathophysiology, diagnosis, and treatment of disseminated intravascular coagulation based on the clinical data

Speaker：

Seiji Madoiwa (Department of Clinical and Laboratory Medicine, Tokyo Saiseikai Central Hospital)

Vascular biology and hemophilia

Speaker：

Nobuyuki Takakura (Department of Signal Transduction, RIMD, Osaka University)

Cardio-oncology: Where do we come from? What are we? Where are we going?

Speaker：

Jun-ichi Abe (University of Texas MD Anderson Cancer Center, USA)

Symposium5

Precision medicine for AML/MDS

Saturday, October 15　15:00-17:00　No.1 Fukuoka International Congress Center 3F Main Hall

Chair：

Yasuhito Nannya (Institute of Medical Science, The University of Tokyo)
Toshihiro Miyamoto (Department of Hematology, Faculty of Medicine, Institute of Medical Pharmaceutical and Health Sciences, Kanazawa University)

Big Data for Novel Therapeutic Strategies in Myeloid Malignancies

Speaker：

Jeffrey W. Tyner (Knight Cancer Institute, Oregon Health & Science University, USA)

Resistance to FLT3 Inhibitors in AML

Speaker：

Catherine Smith (University of California San Francisco, USA)

Venetoclax in AML: what we have learned

Speaker：

Andrew Wei (Peter MacCallum Cancer Centre Walter and Eliza Hall Institute, Australia)

IM-3 signaling hijacks the canonical Wnt/β-catenin pathway to maintain cancer stemness in acute myeloid leukemia

Speaker：

Yoshikane Kikushige (Center for Cellular and Molecular Medicine, Kyushu University Hospital)

Targeting CD47/SIRPα axis for the treatment of MDS/AML

Speaker：

David Sallman (Moffitt Cancer Center, USA)

Symposium6

Towards the best management of MM

Sunday, October 16　9:00-11:00　No.3 Fukuoka International Congress Center 2F 201・202

Chair：

Emiko Sakaida (Department of Hematology, Chiba University Hospital )
Hiroyuki Takamatsu (​Department of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences /Faculty of Transdisciplinary Sciences, Institute of Transdisciplinary Sciences, Kanazawa University)

Molecular biomarkers of MM in clinical practice –advances and perspectives

Speaker：

Brian A. Walker (Indiana University School of Medicine, USA)

Back to cytogenetics with novel concepts in multiple myeloma

Speaker：

Taku Tsukamoto (Division of Hematology and Oncology, Kyoto Prefectural University of Medicine)

Detection of minimal residual disease in multiple myeloma: application for clinical care

Speaker：

Alberto Orfao (University of Salamanca, Spain)

MRD detection in multiple myeloma: Use of MRI imaging and bone marrow

Speaker：

Kentaro Narita (Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center)

Symposium（JSH-EHA Joint Symposium）

Saturday, October 15　15:00-17:00　No.2 Fukuoka International Congress Center 2F 203・204

Recent advances in the management of lymphoid malignancies

Chair：

Koji Izutsu (National Cancer Center Hospital)
Antonio Almeida (Hospital da Luz Lisboa Católica Medical School, Portugal)

EZH inhibitors for Lymphoma

Speaker：

Kenji Ishitsuka (Kagoshima University)

Therapeutic Tax-targeted dendritic cell vaccine produces durable remission in adult T-cell leukemia-lymphoma.

Speaker：

Youko Suehiro (National Hospital Organization Kyushu Cancer Center)

Antibody drug conjugates in the treatment of B-cell lymphomas

Speaker：

Hervé Tilly (Department of Hematology, Centre Henri-Becquerel, Rouen, France)

CD3XCD20 bispecific antibodies for B-cell lymphoma

Speaker：

Martin Hutchings (Department of Haematology, Rigshospitalet and University of Copenhagen, Denmark)

Symposium（JSH-ASH Joint Symposium）

Sunday, October 16　9:00-11:00　No.2 Fukuoka International Congress Center 2F 203・204

CAR-T therapy from the bench to the clinic and back

Chair：

Yoshiki Akatsuka (Department of Immunology, Nagoya University Graduate School of Medicine)
Jane N. Winter (Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, USA)

Memory-rich CAR-T cell engineering by piggyBac transposon system for solid malignancies

Speaker：

Shigeki Yagyu (Department of Pediatrics, Kyoto prefectural University of Medicine)

Identification of multiple myeloma-specific antigens formed by post-translational changes in proteins and development of CAR-T cell therapies targeting them

Speaker：

Naoki Hosen (Department of Hematology and Oncology, Osaka University Graduate School of Medicine)

CD5 knock out enhances the anti-tumor activity of chimeric antigen receptor T cells

Speaker：

Marco Ruella (Center for Cellular Immunotherapy, University of Pennsylvania, USA)

Anti-BCMA CAR T-cell therapy for multiple myeloma

Speaker：

James Kochenderfer (National Cancer Institute, National Institutes of Health, USA)

Women Doctors Career Symposium

Friday, October 14　15:20-17:20　No.2 Fukuoka International Congress Center 2F 203・204

Dreams: Female hematologists'talk

Chair：

Koichi Akashi (Professor,Department of Medicine and Biosystemic Science, Faculty of Medicine, Kyushu University)
Ayako Arai (Division of Hematology & Oncology, Department of Internal Medicine St. Marianna University School of Medicine)

Board certified "hematologist" & "clinical laboratory physicians"; double jobbing - Flow with the tide

Speaker：

Yamazaki Etsuko (Clinical Laboratory Department, Yokohama City University Hospital)

A quarter century as a hematologist in metropolitan emergency hospitals, a researcher of post-transplant survivorship and patient-reported outcomes, and a hematologist-oncologist in the community

Speaker：

Saiko Kurosawa (Ina Central Hospital)

Studies on molecular basis of intractable pediatric hematological cancers

Speaker：

Junko Takita (Department of Pediatrics, Graduate School of Medicine, Kyoto University)

Educational Lecture

Educational Lecture 1-3A

Friday, October 14　9:00-9:30　No.3 Fukuoka International Congress Center 2F 201・202

Chair：

Takahiro Yamauchi (Department of Hematology and Oncology, University of Fukui)

Speaker：

Yoko Tabe (Juntendo University Hospital)

Educational Lecture 1-3B

Friday, October 14　9:40-10:10　No.3 Fukuoka International Congress Center 2F 201・202

Chair：

Matsumura Itaru (Department of Hematology and Rheumatology, Kindai University Faculty of Medicine)

Speaker：

Koichi Takahashi (MD Anderson Cancer Center)

Educational Lecture 1-3C

Friday, October 14　10:20-10:50　No.3 Fukuoka International Congress Center 2F 201・202

Chair：

Naoyuki Uchida (Department of Hematology, Toranomon Hospital)

Speaker：

Naoko Hosono (Department of Blood Transfusion, University of Fukui)

Educational Lecture 1-8A

Friday, October 14　9:00-9:30　No.8 Fukuoka International Congress Center 5F 501

Chair：

Keita Kirito (Department of Hematology and Oncology, University of Yamanashi)

Speaker：

Yoko Edahiro (Department of Hematology, Juntendo University School of Medicine)

Educational Lecture 1-8B

Friday, October 14　9:40-10:10　No.8 Fukuoka International Congress Center 5F 501

Chair：

Katsuto Takenaka (Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine)

Speaker：

Kazuhiko Ikeda (Blood Transfusion and Transplantation Immunology, Fukushima Medical University School of Medicine)

Educational Lecture 1-8C

Friday, October 14　10:20-10:50　No.8 Fukuoka International Congress Center 5F 501

Chair：

Kaoru Tohyama (Department of Laboratory Medicine, Kawasaki Medical School)

Speaker：

Kensuke Usuki (NTT Medical Center Tokyo)

Educational Lecture 1-11A

Friday, October 14　9:00-9:30　No.11 Fukuoka Sunpalace 2F Palace RoomAB

Chair：

Hitoshi Kiyoi (Department of Hematology and Oncology, Nagoya University Graduate School of Medicine)

Speaker：

Ari Itoh-Nakadai (Human Disease Models., IMS, Riken、Hygiene & public Health, Nippon Medical School)

Educational Lecture 1-11B

Friday, October 14　9:40-10:10　No.11 Fukuoka Sunpalace 2F Palace RoomAB

Chair：

Mariko Eguchi (Department of Pediatrics, Ehime University Graduate School of Medicine)

Speaker：

itaru kato (Kyoto university)

Educational Lecture 1-11C

Friday, October 14　10:20-10:50　No.11 Fukuoka Sunpalace 2F Palace RoomAB

Chair：

Shigeki Ito (Department of Hematology & Oncology, Iwate Medical University Hospital)

Speaker：

Michiko Ichii (Department of Hematology and Oncology, Osaka University Graduate School of Medicine)

Educational Lecture 1-3D

Friday, October 14　15:20-15:50　No.3 Fukuoka International Congress Center 2F 201・202

Chair：

Hirohiko Shibayama (Department of Hematology, National Hospital Organization Osaka National Hospital)

Speaker：

Motoko Yamaguchi (Department of Hematological Malignancies, Mie University Graduate School of Medicine)

Educational Lecture 1-3E

Friday, October 14　16:00-16:30　No.3 Fukuoka International Congress Center 2F 201・202

Chair：

Hirokazu Nagai (NHO Nagoya Medical Center)

Speaker：

Yoshihiro Kameoka (Akita University Hospital)

Educational Lecture 1-3F

Friday, October 14　16:40-17:10　No.3 Fukuoka International Congress Center 2F 201・202

Chair：

Kenichi Ishizawa (Yamagata University Faculty of Medicine)

Speaker：

Motoo Nagane (Department of Neurosurgery, Kyorin University Faculty of Medicine)

Educational Lecture 1-11D

Friday, October 14　15:20-15:50　No.11 Fukuoka Sunpalace 2F Palace RoomAB

Chair：

Yuzuru Kanakura (Sumitomo Hospital)

Speaker：

Yasutaka Ueda (Department of Hematology and Oncology, Osaka University Graduate School of Medicine)

Educational Lecture 1-11E

Friday, October 14　16:00-16:30　No.11 Fukuoka Sunpalace 2F Palace RoomAB

Chair：

Yutaka Yatomi (Department of Clinical Laboratory Medicine, Graduate School of Medicine, The University of Tokyo)

Speaker：

Atsushi Yasumoto (Hokkaido University Hospital)

Educational Lecture 1-11F

Friday, October 14　16:40-17:10　No.11 Fukuoka Sunpalace 2F Palace RoomAB

Chair：

tadashi matsushita (Department of TRansfusion Medicine, Nagoya University Hospital)

Speaker：

Tazuko　 Tokugawa (Department of Hematology, Hyogo College of Medicine Hospital)

Educational Lecture 2-3A

Saturday, October 15　9:00-9:30　No.3 Fukuoka International Congress Center 2F 201・202

Chair：

Koji Kato (Kyushu University Hospital)

Speaker：

Yuki Kagoya (Aichi Cancer Center Research Institute)

Educational Lecture 2-3B

Saturday, October 15　9:40-10:10　No.3 Fukuoka International Congress Center 2F 201・202

Chair：

Kadowaki Norimitsu (Department of Internal Medicine, Faculty of Medicine, Kagawa University)

Speaker：

Shin Kaneko (Center for iPS Cell Research and Application, Kyoto University、Faculty of Medicine, Tsukuba University)

Educational Lecture 2-3C

Saturday, October 15　10:20-10:50　No.3 Fukuoka International Congress Center 2F 201・202

Chair：

Nakazawa Yozo (Department of Pediatrics, Shinshu University School of Medicine)

Speaker：

Miki Ando (Department of Hematology, Juntendo University School of Medicine)

Educational Lecture 2-8A

Saturday, October 15　9:00-9:30　No.8 Fukuoka International Congress Center 5F 501

Chair：

Hironori Harada (Laboratory of Oncology, Tokyo University of Pharmacy and Life Sciences)

Speaker：

Koji Ando (Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University)

Educational Lecture 2-8B

Saturday, October 15　9:40-10:10　No.8 Fukuoka International Congress Center 5F 501

Chair：

Tomohiko Tamura (Yokohama City University)

Speaker：

Ryo Yamamoto (Kyoto University Institute for the Advanced Study of Human Biology （ASHBi）)

Educational Lecture 2-8C

Saturday, October 15　10:20-10:50　No.8 Fukuoka International Congress Center 5F 501

Chair：

Shouichi Ohga (Department of Pediatrics, Graduate School of Medical Science, Kyushu University)

Speaker：

Etsuro Ito (Hirosaki University Graduate School of Medicine, Department of Community Medicine)

Educational Lecture 2-11A

Saturday, October 15　9:00-9:30　No.11 Fukuoka Sunpalace 2F Palace RoomAB

Chair：

Nao Yoshida (Department of Hematology and Oncology, Children's Medical Center, Japanese Red Cross Aichi Medical Center Nagoya First Hospital)

Speaker：

Hideki Muramatsu (Department of Pediatrics, Nagoya University Graduate School of Medicine)

Educational Lecture 2-11B

Saturday, October 15　9:40-10:10　No.11 Fukuoka Sunpalace 2F Palace RoomAB

Chair：

Takako Miyamura (Department of Pediatrics, Osaka University Graduate School of Medicine)

Speaker：

Yuhki Koga (Department of Perinatal and Pediatric Medicine/ Department of Pediatrics Kyushu University)

Educational Lecture 2-11C

Saturday, October 15　10:20-10:50　No.11 Fukuoka Sunpalace 2F Palace RoomAB

Chair：

Etsuko Yamazaki (Clinical Laboratory Department, Yokohama City University Hospital)

Speaker：

Atsushi Sato (Department of Hematology and Oncology, Miyagi Children's Hospital)

Educational Lecture 2-3D

Saturday, October 15　15:00-15:30　No.3 Fukuoka International Congress Center 2F 201・202

Chair：

Keiya Ozawa (Jichi Medical University)

Speaker：

Yusuke Furukawa (Jichi Medical University)

Educational Lecture 2-3E

Saturday, October 15　15:40-16:10　No.3 Fukuoka International Congress Center 2F 201・202

Chair：

Masahiro Kizaki (Department of Hematology, Saitama Medical Center, Saitama Medical University)

Speaker：

Yoichi Imai (Department of Hematology and Oncology, Dokkyo Medical University School of Medicine)

Educational Lecture 2-3F

Saturday, October 15　16:20-16:50　No.3 Fukuoka International Congress Center 2F 201・202

Chair：

Masahiro Abe (Department of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School)

Speaker：

Takashi Ikeda (Division of Hematology and Stem Cell Transplantation, Shizuoka Cancer Center)

Educational Lecture 2-8D

Saturday, October 15　15:00-15:30　No.8 Fukuoka International Congress Center 5F 501

Chair：

Mitsuru Murata (Keio University School of Medicine)

Speaker：

Takao Kobayashi (Hamamatsu Medical Center)

Educational Lecture 2-8E

Saturday, October 15　15:40-16:10　No.8 Fukuoka International Congress Center 5F 501

Chair：

Naoto Takahashi (Akita University)

Speaker：

Takeshi Kondo (Aiiku Hospital)

Educational Lecture 2-8F

Saturday, October 15　16:20-16:50　No.8 Fukuoka International Congress Center 5F 501

Chair：

Nakamae  Hirohisa (Hematology, Graduate School of Medicine, Osaka Metropolitan University)

Speaker：

Shinsuke Takagi (Department of Hematology, Toranomon Hospital)

Educational Lecture 3-8A

Sunday, October 16　9:00-9:30　No.8 Fukuoka International Congress Center 5F 501

Chair：

Makoto Murata (Department of Hematology and Oncology, Nagoya University Graduate School of Medicine)

Speaker：

Daigo Hashimoto (Hokkaido University Faculty of Medicine)

Educational Lecture 3-8B

Sunday, October 16　9:40-10:10　No.8 Fukuoka International Congress Center 5F 501

Chair：

Takahiro Fukuda (Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital)

Speaker：

Yoshinobu Kanda (Jichi Medical University)

Educational Lecture 3-8C

Sunday, October 16　10:20-10:50　No.8 Fukuoka International Congress Center 5F 501

Chair：

Takanori Teshima (Hokkaido University)

Speaker：

Koji Nagafuji (Division of Hematology & Oncology, Department of Medicine, Kurume University School of Medicine)

Educational Lecture 3-11A

Sunday, October 16　9:00-9:30　Fukuoka Sunpalace 2F Palace RoomAB

Chair：

Keiyo Takubo (National Center for Global Health and Medicine Research Institute)

Speaker：

Kenichi Miharada (International Research Center for Medical Sciences, Kumamoto University)

Educational Lecture 3-11B

Sunday, October 16　9:40-10:10　No.11 Fukuoka Sunpalace 2F Palace RoomAB

Chair：

Yoshio Katayama (Hematology, Kobe University Hospital)

Speaker：

Noboru Asada (Okayama University Hospital)

Educational Lecture 3-11C

Sunday, October 16　10:20-10:50　No.11 Fukuoka Sunpalace 2F Palace RoomAB

Chair：

Masayuki Hino (Osaka City University)

Speaker：

Haruka Nakada (National Cancer Center,)

Educational Lecture 3-12A

Sunday, October 16　9:00-9:30　No.12 Marine Messe Fukuoka Hall B 2F Meeting Room1

Chair：

Atsushi Manabe (Department of Pediatrics, Hokkaido University Graduate School of Medicine)

Speaker：

Asahito Hama (Department of Hematology and Oncology, Children's Medical Center, Japanese Red Cross Aichi Medical Center Nagoya First Hospital)

Educational Lecture 3-12B

Sunday, October 16　9:40-10:10　No.12 Marine Messe Fukuoka Hall B 2F Meeting Room1

Chair：

Yuki Asano-Mori (Toranomon Hospital)

Speaker：

Chikako Kiyotani (National Center for Child Health and Development)

Educational Lecture 3-3D

Sunday, October 16　13:20-13:50　No.3 Fukuoka International Congress Center 2F 201・202

Chair：

Akihiro Tomita (Department of Hematology, Fujita Health University School of Medicine)

Speaker：

Makoto Yamagishi (Graduate School of Frontier Sciences, The University of Tokyo)

Educational Lecture 3-3E

Sunday, October 16　14:00-14:30　No.3 Fukuoka International Congress Center 2F 201・202

Chair：

Seishi Ogawa (Department of pathology and tumor biology, Graduate School of Medicine, Kyoto University)

Speaker：

Keisuke Kataoka (Division of Hematology Department of Medicine Keio University School of Medicine)

Educational Lecture 3-3F

Sunday, October 16　14:40-15:10　No.3 Fukuoka International Congress Center 2F 201・202

Chair：

Masaki Yasukawa (Ehime Prefectural University of Health Sciences)

Speaker：

Toshiki Ochi (Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine)

Educational Lecture 3-8D

Sunday, October 16　13:20-13:50　No.8 Fukuoka International Congress Center 5F 501

Chair：

Hidesaku Asakura (Department of Hematology, Kanazawa University Hospital)

Speaker：

Yasuyuki Arai (Kyoto University Hospital)

Educational Lecture 3-8E

Sunday, October 16　14:00-14:30　No.8 Fukuoka International Congress Center 5F 501

Chair：

Hideo Harigae (Dep. Hematol. Tohoku University Hospital)

Speaker：

Katsuya Ikuta (Hokkaido Blood Center)

Educational Lecture 3-8F

Sunday, October 16　14:40-15:10　No.8 Fukuoka International Congress Center 5F 501

Chair：

Takahiro Suzuki (Department of Hematology, Kitasato University School of Medicine)

Speaker：

Hideki Makishima (Kyoto University)

<Live Streaming Distribution>

Corporate Seminar

Luncheon Seminar1-1

14-Oct (Fri) 12:00-12:45 No.1 Fukuoka International Congress Center 3F Main Hall

Sponsor: Takeda Pharmaceutical Company Limited

Chair:

Takashi Ikeda
(Division of Hematology and Stem Cell Transplantation, Shizuoka Cancer Center)

Maintenance therapy for transplant-eligible multiple myeloma from a view of clinical practice.

Speaker:

Kentaro Serizawa
(Department of Hematology and Rheumatology, Kindai University Faculty of Medicine)

Maintenance therapy for transplant-ineligible multiple myeloma and significance of PI based continuous therapy from a view of clinical practice.

Speaker:

Makoto Sasaki
(Department of Hematology, Juntendo University School of Medicine)

Luncheon Seminar1-2

14-Oct (Fri) 12:00-12:45 No.2 Fukuoka International Congress Center 2F 203･204

Treatment Strategy for newly diagnosed chronic phase chronic myeloid leukemia

Sponsor: Pfizer Japan Inc.

Chair:

Chiaki Nakaseko
(Department of Hematology, International University of Health and Welfare School of Medicine)

Speaker:

Takaaki Ono
(Department of Blood Transfusion and Cell Therapy,Hamamatsu University Hospital)

Luncheon Seminar1-3

14-Oct (Fri) 12:00-12:45 No.3 Fukuoka International Congress Center 2F 201･202

Treatment strategy of relapsed/refractory PTCL

Sponsor: Meiji Seika Pharma Co., Ltd.

Chair:

Akihiro Tomita
(FUJITA HEALTH UNIVERSITY School of Medicine Hematology)

Speaker:

Takahiro Kumode
(Kindai University Faculty of Medicine Department of Hematology and  Rheumatology)

Luncheon Seminar1-4

14-Oct (Fri) 12:00-12:45 No.4 Fukuoka International Congress Center 4F 411･412

Statistical Considerations in Clinical Trials with Long-Term Prognosis -Using Obinutuzumab-Related Trials Data

Sponsor: Chugai Pharmaceutical Co., Ltd./ Nippon Shinyaku Co., Ltd.

Chair:

Ken Ohmachi
(Department of Internal Medicine, Division of Hematology and Oncology, Tokai University School of Medicine)

Speaker:

Kenta Murotani
(Biostatistics Center, Kurume University)

Luncheon Seminar1-5

14-Oct (Fri) 12:00-12:45 No.5 Fukuoka International Congress Center 4F 413･414

Infection control in hematologic malignancy~Focusing on Fungus and CMV~

Sponsor: MSD K.K.

Chair:

Naoyuki Uchida
(Department of Hematology, Toranomon Hospital)

Strategies to prevent fungal infection in patients with hematologic malignancies

Speaker:

Hiroki Yokoyama
(Clin. Oncol. Hematol. Div., The Jikei Univ., Tokyo, Japan)

CMV management after transplantation in prophylaxis era

Speaker:

Takashi Toya
(Hematology Division, Tokyo Metropolitan Komagome Hospital)

Luncheon Seminar1-6

14-Oct (Fri) 12:00-12:45 No.6 Fukuoka International Congress Center 4F 409･410

Paradigm Shift from Chemotherapy to Immunotherapy: Transplant-Ineligible B-ALL

Sponsor: Astellas Pharma Inc. / Amgen K.K.

Chair:

Takahiro Yamauchi
(Department of Hematology and Oncology, University of Fukui Hospital)

Speaker:

Yasushi Onishi
(Department of Hematology, Tohoku University Hospital)

Luncheon Seminar1-7Live Recording On-demand

14-Oct (Fri) 12:00-12:45 No.7 Fukuoka International Congress Center 4F 404･405･406

Pitfalls in Clinical Practice for PV and ET

Sponsor: PharmaEssentia Japan KK.

Chair:

Hiroki Yamaguchi
(Department of Hematology, Nippon Medical School)

Speaker:

Yuka Sugimoto
(Department of Hematology and Oncology, Mie University Graduate School of Medicine)

Luncheon Seminar1-8Live Recording On-demand

14-Oct (Fri) 12:00-12:45 No.8 Fukuoka International Congress Center 5F 501

Looking for New Ways of Care in Hematology -Take Action for the Work Style Reforms of Doctors in 2024-

Sponsor: Novartis Pharma K.K.

Chair:

Itaru Matsumura
(Department of Hematology and Rheumatology,Kindai University,Faculty of Medicine, Osaka, Japan)

Regional Care System for Hematologic Disorders in Kurume Area

Speaker:

Takashi Okamura
(Division of Hematology, St. Mary's Hospital, Kurume, Japan)

The latest trends in work style reforms for doctors

Speaker:

Eishu Hai
(Highz-Inc./Keio University, Tokyo, Japan)

Luncheon Seminar1-9

14-Oct (Fri) 12:00-12:45 No.9 Fukuoka International Congress Center 5F 502

Treatment Strategy of PTCL 2022 - To the new stage -

Sponsor: Mundipharma K.K

Chair:

Kazuhito Yamamoto
(Aichi Cancer Center, Nagoya, Japan)

Speaker:

Tomoki Ito
(First Department of Internal Medicine, Kansai Medical University, Osaka, Japan)

Luncheon Seminar1-10

14-Oct (Fri) 12:00-12:45 No.10 Fukuoka International Congress Center 5F 503

Tasks and correspondence on stable supply of prescription drugs

Sponsor: Shionogi & Co. , LTD.

Chair:

Naoki Hosen
(Department of Hematology and Oncology. Osaka University Graduate School of Medicine)

Speaker:

Hiroshi Kiyota
(The Jikei University School of Medicine/Iguchi Nephrourology and Internal Medicine Shinkoiwa)

Luncheon Seminar1-11

14-Oct (Fri) 12:00-12:45 No.11 Fukuoka Sunpalace 2F Palace Room AB

AML in 2022: a year of change

Sponsor: AbbVie GK

Chair:

Takahiro Maeda
(Division of Precision Medicine, Kyushu University School of Medicine)

Speaker:

Andrew Wei
(Peter MacCallum Cancer Centre, Royal Melbourne Hospital, Walter and Eliza Hall Institute of Medical Research and University of Melbourne, Australia)

Luncheon Seminar1-12

14-Oct (Fri) 12:00-12:45 No.12 Marine Messe Fukuoka Hall B 2F Meeting Room 1

Importance of MRD test on flow cytometry for AML treatment strategy

Sponsor: Nippon Becton Dickinson Company, Ltd.

Chair:

Yoshikane Kikushige
(Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka, Japan)

Speaker:

Teppei Sakoda
(Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka, Japan)

Luncheon Seminar1-13Live Recording On-demand

14-Oct (Fri) 12:00-12:45 No.13 Marine Messe Fukuoka Hall B 2F Meeting Room 2

The intersection of host defense and iron metabolism – Clinical utility of hepcidin measurements –

Sponsor: FUJIFILM Wako Pure Chemical Corporation

Chair:

Yasunori Ueda
(Kurashiki Central Hospital)

Speaker:

Hiroshi Kawabata
(National Hospital Organization Kyoto Medical Center)

Online Seminar1-1

14-Oct (Fri) 12:00-12:45 WEB   

Let's visualize the joints！Nuwiq and Treatment of Hemophilia at Ogikubo Hospital

Sponsor: Fujimoto Pharmaceutical Corporation

Chair:

Tazuko Tokugawa
(Department of Hematology, Hyogo College of Medicine Hospital)

Speaker:

Azusa Nagao
(Department of Blood Coagulation Ogikubo Hospital)

Online Seminar1-2Live Recording On-demand

14-Oct (Fri) 15:20-16:05 WEB   

Strategies for Preventing Infectious Diseases for Patients with Hematological Malignancy -Vaccine Preventable Diseases (VPD)-

Sponsor: GlaxoSmithKline K.K.

Chair:

Yuki Asano-Mori
(Department of Transfusion Medicine, Center for long-term follow-up after Hematopoietic stem cell transplantation, Tranomon Hospital)

Vaccines recommended for hematological malignancy survivors

Speaker:

Keiji Okinaka
(Department of Infectious Diseases, National Cancer Center Hospital East, and Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital)

Evening Seminar1-2Live Recording On-demand

14-Oct (Fri) 17:40-18:25 No.2 Fukuoka International Congress Center 2F 203･204

Learning from clinical practice: Patients to consider for CAR-T therapy and collaboration between referral/CAR-T treatment centers

Sponsor: Novartis Pharma K.K.

Chair:

Jun Kato
(Division of Hematology, Department of Medicine, Keio University, Tokyo, Japan)

Speaker:

Nobuharu Fujii
(Division of Blood Transfusion, Okayama University Hospital, Okayama, Japan)

Evening Seminar1-3

14-Oct (Fri) 17:40-18:25 No.3 Fukuoka International Congress Center 2F 201･202

Therapeutic strategy for multiple myeloma considering tumor microenvironment

Sponsor: Bristol Myers Squibb

Chair:

Masahiro Abe
(Department of Hematology, Endocrinology and Metabolism, Institute of Biomedical Sciences, Tokushima University Graduate School, Japan.)

Speaker:

Yoshiki Akatsuka
(Department of Immunology, Nagoya University Graduate School of Medicine, Japan)

Evening Seminar1-4

14-Oct (Fri) 17:40-18:25 No.4 Fukuoka International Congress Center 4F 411･412

Long-term follow-up after transplantation and tips for outpatient care

Sponsor: Medical Affairs Division, Janssen Pharmaceutical K.K.

Chair:

Masayuki Hino
(Department of Hematology, Graduate School of Medicine, Osaka Metropolitan University)

Speaker:

Yoshihiro Inamoto
(Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital)

Evening Seminar1-5

14-Oct (Fri) 17:40-18:25 No.5 Fukuoka International Congress Center 4F 413･414

Clinical practice for pediatric to young adult lymphoma patients

Sponsor: Takeda Pharmaceutical Company Limited

Chair:

Keizo Horibe
(Clinical Research Center and Department of Pediatrics, National Hospital Organization Nagoya Medical Center)

Speaker:

Masahiro Sekimizu
(Clinical Research Center and Department of Pediatrics, National Hospital Organization Nagoya Medical Center)

Evening Seminar1-6

14-Oct (Fri) 17:40-18:25 No.6 Fukuoka International Congress Center 4F 409･410

Clonal Evolution of Follicular Lymphoma

Sponsor: Medical HQs, Eisai Co., Ltd.

Chair:

Karube Kennosuke
(High-Technology Application of Medicine Pathology and Laboratory Medicine/Diagnostic Pathology Nagoya University Graduate School of Medicine)

Speaker:

Jessica Okosun
(Queen Mary University of London)

Evening Seminar1-7

14-Oct (Fri) 17:40-18:25 No.7 Fukuoka International Congress Center 4F 404･405･406

Looking back on the evidence for essential thrombocythemia

Sponsor: Takeda Pharmaceutical Company Limited

Chair:

Katsuto Takenaka
(Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine)

Speaker:

Yoshinori Hashimoto
(Department of Hematology, Tottori Prefectural Central hospital, Tottori, Japan)

Evening Seminar1-8

14-Oct (Fri) 17:40-18:25 No.8 Fukuoka International Congress Center 5F 501

Cold Agglutinin Disease -The future of CAD treatment with Enjaymo^®-

Sponsor: Sanofi K.K.

Chair:

Hideo Harigae
(Department of Hematology, Tohoku University Graduate School of Medicine)

Speaker:

Masaki Yamaguchi
(Department of Hematology, Ishikawa Prefectural Central Hospital)

Evening Seminar1-9

14-Oct (Fri) 17:40-18:25 No.9 Fukuoka International Congress Center 5F 502

New Insights in a New Era of Hemophilia Treatment

Sponsor: CSL Behring K.K.

Chair:

Koji Yada
(Division of Hemophilia, National Hospital Organization Osaka National Hospital)

Tailored treatment for "primary prophylaxis native generation" with hemophilia

Speaker:

Rie Shirayama
(Department of Pediatrics, University of Occupational and Environmental Health, Japan)

When is it better to change adult hemophilia treatment？

Speaker:

Yushi Chikasawa
(Department of Laboratory Medicine, Tokyo Medical University)

Evening Seminar1-10

14-Oct (Fri) 17:40-18:25 No.10 Fukuoka International Congress Center 5F 503

CAR T-cell therapy Challenges and Overcoming Based on the Real-World Evidence

Sponsor: Gilead Sciences K.K. Kite cell therapy/Medical Affairs

Chair:

Kiyoshi Ando
(Department of Hematology and Oncology, Tokai University School of Medicine)

Speaker:

Hideki Goto
(Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital)

Evening Seminar1-11

14-Oct (Fri) 17:40-18:25 No.11 Fukuoka Sunpalace 2F Palace Room AB

Recent trends in TMA medical treatment －Differential diagnosis from TA-TMA －

Sponsor: Alexion Pharma GK

Chair:

Eriko Morishita
(Department of Laboratory Science, School of Health Sciences, College of Medical, Pharmaceutical and Health Sciences, Kanazawa University)

Speaker:

Masanori Matsumoto
(Department of Blood Transfusion Medicine, Nara Medical University)

Evening Seminar1-12

14-Oct (Fri) 17:40-18:25 No.12 Marine Messe Fukuoka Hall B 2F Meeting Room 1

Reconsideration of antifungal stewardship in patients with hematologic malignancies

Sponsor: Sumitomo Pharma Co.,Ltd.

Chair:

Shuichi Taniguchi
(Department of Hematology, Hamanomachi Hospital)

Speaker:

Tohru Takata
(Department of Infection Control, Fukuoka University Hospital/Department of Oncology, Hematology and Infectious Diseases, Faculty of Medicine, Fukuoka University)

Evening Seminar1-13

14-Oct (Fri) 17:40-18:25 No.13 Marine Messe Fukuoka Hall B 2F Meeting Room 2

Therapeutic Strategies for Relapsed/Refractory ALL with Besponsa

Sponsor: Pfizer Japan Inc.

Chair:

Yoshihiro Hatta
(Division of Hematology and Rheumatology, Nihon University School of Medicine)

Speaker:

Junichi Sugita
(Department of Hematology, Sapporo Hokuyu Hospital)

Morning Seminar2-1

15-Oct (Sat) 8:00-8:45 No.1 Fukuoka International Congress Center 3F Main Hall

Current therapy for MM UpToDate -2022

Sponsor: Bristol Myers Squibb

Chair:

Emiko Sakaida
(Chiba univrsity Hospital department of Hematology)

Speaker:

Tadao Ishida
(Japan Red Cross Medical center department of Hematology)

Morning Seminar2-2

15-Oct (Sat) 8:00-8:45 No.2 Fukuoka International Congress Center 2F 203･204

A new paradigm in the treatment of refractory or intolerant CML

Sponsor: Novartis Pharma K.K.

Chair:

Michihide Tokuhira
(Japan Community Health Care Organization Saitama Medical Center Department of Hematology, Saitama, Japan)

Speaker:

Eri Matsuki
(Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan)

Morning Seminar2-3

15-Oct (Sat) 8:00-8:45 No.3 Fukuoka International Congress Center 2F 201･202

Mantle Cell Lymphoma - from the past to today's standards.

Sponsor: Janssen Pharmaceutical K.K.

Chair:

Maruyama Dai
(Department of Hematology Oncology, Cancer Institute Hospital of Japan Foundation for Cancer Research, Japan)

Speaker:

Georg Heß
(Department of Hematology, Oncology and Pneumology University Medical School of the Johannes Gutenberg University, Germany)

Morning Seminar2-4

15-Oct (Sat) 8:00-8:45 No.4 Fukuoka International Congress Center 4F 411･412

Past and future perspective of autologous stem cell transplantation in the era of plerixafor

Sponsor: Sanofi K.K.

Chair:

Shuichi Ota
(Department of Hematology, Sapporo Hokuyu Hospital, Japan)

Speaker:

Nobuhiro Tsukada
(Department of Hematology, Japanese Red Cross Medical Center, Japan)

Morning Seminar2-5

15-Oct (Sat) 8:00-8:45 No.5 Fukuoka International Congress Center 4F 413･414

Clinical insight into sinusoidal obstruction syndrome -diagnosis and treatment-

Sponsor: Nippon Shinyaku Co., Ltd.

Chair:

Kimikazu Yakushijin
(Division of Medical Oncology/Hematology, Kobe University Graduate School of Medicine)

Speaker:

Shinsuke Takagi
(Department of Hematology, Toranomon Hospital, Federation of National Public Service Personnel Mutual Aid Association)

Morning Seminar2-6

15-Oct (Sat) 8:00-8:45 No.6 Fukuoka International Congress Center 4F 409･410

Therapeutic strategy for WM / LPL

Sponsor: ONO PHARMACEUTICAL CO., LTD.

Chair:

Hirohiko Shibayama
(Department of hematology, NHO Osaka National Hospital)

Speaker:

Steven P Treon
(Bing Center for Waldenstrom's Macroglobulinemia, Dana-Farber Cancer Institute)

Morning Seminar2-7

15-Oct (Sat) 8:00-8:45 No.7 Fukuoka International Congress Center 4F 404･405･406

B-cell acute lymphoblastic leukemia; Update on Treatment Strategies

Sponsor: Medical Affairs, Amgen K.K / Medical Affairs, Astellas Pharma Inc.

Chair:

Etsuko Yamazaki
(Clinical Laboratory Department, Yokohama City University Hospital)

Speaker:

Akihito Shinohara
(Department of Hematology, Tokyo Women's Medical University)

Morning Seminar2-8

15-Oct (Sat) 8:00-8:45 No.8 Fukuoka International Congress Center 5F 501

Treatment Strategy for DIC (disseminated intravascular coagulation) – sepsis･acute leukemia –

Sponsor: Asahi Kasei Pharma Corporation

Chair:

Shosaku Nomura
(Center of Thrombosis and Hemostasis, Kansai Medical University Medical Center)

Roles of thrombomodulin in sepsis-associated DIC

Speaker:

Takashi Ito
(Department of Biomedical Laboratory Sciences, Faculty of Life Sciences, Kumamoto University)

Anticoagulation for acute leukemia DIC –Answers to your hesitation-

Speaker:

Yoshinobu Seki
(Department of Hematology, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital)

Morning Seminar2-9

15-Oct (Sat) 8:00-8:45 No.9 Fukuoka International Congress Center 5F 502

Points of chemotherapy for relapsed or refractory PTCL

Sponsor: Nippon Kayaku Co.,Ltd.

Chair:

Yasuhito Terui
(Department of Hematology, Saitama Medical University Hospital, Saitama, Japan)

Speaker:

Eiju Negoro
(Department of Hematology and Oncology, University of Fukui, Fukui, Japan)

Morning Seminar2-11

15-Oct (Sat) 8:00-8:45 No.11 Fukuoka Sunpalace 2F Palace Room AB

Biology of follicular lymphoma and its clinical significance targeting immune microenvironment

Sponsor: Bristol Myers Squibb

Chair:

Kenji Ishitsuka
(Department of Hematology and Rheumatology, Kagoshima University Hospital)

Speaker:

Daisuke Ennishi
(Center for Comprehensive Genomic Medicine, Okayama University Hospital)

Morning Seminar2-12

15-Oct (Sat) 8:00-8:45 No.12 Marine Messe Fukuoka Hall B 2F Meeting Room 1

Diagnosis and Treatment of Acquired Hemophilia A

Sponsor: Takeda Pharmaceutical Company Limited

Chair:

Takamitsu Okamura
(Dokkyo Medical University Saitama Medical Center)

Speaker:

Nobuaki Suzuki
(Nagoya University Hospital)

Morning Seminar2-13

15-Oct (Sat) 8:00-8:45 No.13 Marine Messe Fukuoka Hall B 2F Meeting Room 2

Positioning of Transplantation and CAR T Cell Therapy in DLBCL

Sponsor: Daiichi Sankyo Co., Ltd.

Chair:

Kaoru Kahata
(Hokkaido University Hospital Institute of Health Science Innovation for Medical Care)

Speaker:

Junya Kanda
(Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University)

Luncheon Seminar2-1

15-Oct (Sat) 12:10-12:55 No.1 Fukuoka International Congress Center 3F Main Hall

-Two years have passed since the Sarclisa^® have launched - Considering the position of Sarclisa from the basic and clinical perspectives.

Sponsor: Sanofi K.K.

Chair:

Kenshi Suzuki
(Department of Myeloma-Amyloidosis center, Japanese Red Cross Medical Center)

Speaker:

Yusuke Furukawa
(Division of Stem Cell Regulation, Center for Molecular Medicine, Jichi Medical University)

Speaker:

Shigeki Ito
(Hematology & Oncology, Department of Internal Medicine, Iwate Medical University School of Medicine)

Luncheon Seminar2-2

15-Oct (Sat) 12:10-12:55 No.2 Fukuoka International Congress Center 2F 203･204

How to Optimize Immune-based Therapy in Early Line RRMM

Sponsor: Bristol Myers Squibb

Chair:

Shuji Ozaki
(Department of Hematology, Tokushima Prefecture Central Hospital)

Mechanism of Actions for Pomalidomide-combined Anti-CD38 Antibody Regimens
- Immune-based Therapy -

Speaker:

Akihiro Kitadate
(Department of Hematology, Nephrology, and Rheumatology/Clinical Research Promotion and Support Center, Akita University Hospital)

How to use Pomalidomide-intensified Antibody Therapy From the Viewpoint of
Immunological Pathology

Speaker:

Hideto Tamura
(Division of Diabetes, Endocrinology and Hematology, Department of Internal Medicine, Dokkyo Medical University Saitama Medical Center)

Luncheon Seminar2-3

15-Oct (Sat) 12:10-12:55 No.3 Fukuoka International Congress Center 2F 201･202

Cutting edge of genomic medicine and therapeutic strategy with azacitidine in unfit/refractory AML

Sponsor: Nippon Shinyaku Co., Ltd.

Chair:

Masahiro Kizaki
(Department of Hematology, Saitama Medical Center, Saitama Medical University)

Speaker:

Yosuke Minami
(Department of Hematology, National Cancer Center Hospital East)

Luncheon Seminar2-4

15-Oct (Sat) 12:10-12:55 No.4 Fukuoka International Congress Center 4F 411･412

PNH therapeutic strategy focusing on inhibition of intravascular hemolysis

Sponsor: Alexion Pharma GK

Chair:

Takahiro Suzuki
(Department of Hematology, Kitasato University School of Medicine)

Speaker:

Junichi Nishimura
(Department of Hematology and Oncology, Osaka University Graduate School of Medicine)

Luncheon Seminar2-5

15-Oct (Sat) 12:10-12:55 No.5 Fukuoka International Congress Center 4F 413･414

AML treatment targeting FLT3 mutations

Sponsor: Daiichi Sankyo Co., Ltd.

Chair:

Yasushi Miyazaki
(Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University)

Speaker:

Yuichi Ishikawa
(Nagoya University Hospital)

Luncheon Seminar2-6

15-Oct (Sat) 12:10-12:55 No.6 Fukuoka International Congress Center 4F 409･410

Management of infectious complications in allogeneic transplant recipients

Sponsor: Asahi Kasei Pharma Corporation

Chair:

Koji Nagafuji
(Division of Hematology & Oncology, Department of Medicine,Kurume University School of Medicine)

Speaker:

Yoshinobu Kanda
(Division of Hematology, Department of Medicine, Jichi Medical University Division of Hematology, Jichi Medical University Saitama Medical Center)

Luncheon Seminar2-7

15-Oct (Sat) 12:10-12:55 No.7 Fukuoka International Congress Center 4F 404･405･406

Treatment strategy for acquired aplastic anemia -Potential of TPO-RA-

Sponsor: kyowa kirin co. ltd

Chair:

Kinuko Mitani
(Department of Hematology and Oncology, Dokkyo Medical University)

Speaker:

Naoshi Obara
(University of Tsukuba, Faculty of Medicine, Department of Medical Sciences, Hematology)

Luncheon Seminar2-8

15-Oct (Sat) 12:10-12:55 No.8 Fukuoka International Congress Center 5F 501

Transplant-Ineligible Multiple Myeloma -Therapeutic transformation from a clinical perspective-

Sponsor: Janssen Pharmaceutical K.K.

Chair:

Toshihiro Miyamoto
(Department of Hematology,Faculty of Medicine, Institute of Medical Pharmaceutical and Health Sciences, Kanazawa University)

Speaker:

Tomohiko Kamimura
(Department of Hematology, Harasanshin Hospital)

Luncheon Seminar2-9

15-Oct (Sat) 12:10-12:55 No.9 Fukuoka International Congress Center 5F 502

How Should We Treat Patients with Hematologic Malignancies Complicated by Secondary Hypogammaglobulinemia? ~Algorithm and Pitfalls of Immunoglobulin Replacement Therapy~

Sponsor: CSL Behring K.K.

Chair:

Yotaro Tamai
(Division of Hematology, Shonan Kamakura General Hospital)

Speaker:

Keichiro Mihara
(Department of International Center for Cell and Gene Therapy, Fujita Health University/Advanced Cancer Immunotherapy, Fujita Health University Graduate School of Medicine)

Luncheon Seminar2-10

15-Oct (Sat) 12:10-12:55 No.10 Fukuoka International Congress Center 5F 503

Treatment strategy for CLL

Sponsor: ZENYAKU KOGYO CO., LTD.

Chair:

Junji Suzumiya
(Community Hospital Koga Hospital)

Speaker:

Yasushi Isobe
(Department of Medical Oncology, Hematology and Infectious Diseases, Fukuoka University Hospital)

Luncheon Seminar2-11

15-Oct (Sat) 12:10-12:55 No.11 Fukuoka Sunpalace 2F Palace Room AB

From the clinical scene of treatment with Carfilzomib for relapsed/refractory myeloma

Sponsor: ONO PHARMACEUTICAL CO., LTD.

Chair:

Shinsuke Iida
(Department of Hematology and Oncology, Nagoya City University Institute of Medical and Pharmaceutical Sciences)

Speaker:

Jyuya Kuroda
(Division of Hematology and Oncology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine)

Luncheon Seminar2-12

15-Oct (Sat) 12:10-12:55 No.12 Marine Messe Fukuoka Hall B 2F Meeting Room 1

Treatment strategy of relapsed/refractory follicular lymphoma

Sponsor: Eisai Co., Ltd.

Chair:

Koji Izutsu
(Department of Hematology, National Cancer Center Hospital)

Speaker:

Loretta J. Nastoupil
(Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center)

Luncheon Seminar2-13

15-Oct (Sat) 12:10-12:55 No.13 Marine Messe Fukuoka Hall B 2F Meeting Room 2

Latest updates in treatment of CLL

Sponsor: AstraZeneca.K.K

Chair:

Yasushi Takamatsu
(Division of Medical Oncology, Hematology and Infectious Diseases, Department of Internal Medicine, Fukuoka University)

Speaker:

Jeff Sharman
(Hematology Research, US Oncology Network)

Online Seminar2-1

15-Oct (Sat) 12:10-12:55 WEB   

Current situation and issues for treatment of PCNSL

Sponsor: OHARA Pharmaceutical Co.,Ltd.

Chair:

Kisato Nosaka
(Cancer center, Kumamoto University)

Speaker:

Motoo Nagane
(Department of Neurosurgery, Kyorin University Faculty of Medicine)

Online Seminar2-2

15-Oct (Sat) 15:00-15:45 WEB   

Mantle Cell Lymphoma,Diagnostic and Current Therapeutic Evidence

Sponsor: Eli Lilly Japan K.K.

Chair:

Kensuke Kojima
(Department of Hematology, Kochi University)

Speaker:

Shigeru Kusumoto
(Department of Hematology & Oncology, Nagoya City University Graduate School of Medical Sciences)

Industry Session2-2Live Recording On-demand

15-Oct (Sat) 17:20-17:50 No.2 Fukuoka International Congress Center 2F 203･204

The importance of managing intravascular hemolysis in patients with PNH ーWhat we have learned over the past decadeー

Sponsor: Alexion Pharma GK

Chair:

Shinji Nakao
(Ishikawa Red Cross Blood Center)

Speaker:

Yasutaka Ueda
(Department of Hematology & Oncology, Osaka Universtity Graduate School of Medicine )

Industry Session2-3

15-Oct (Sat) 17:20-17:50 No.3 Fukuoka International Congress Center 2F 201･202

Treatment Strategy for Follicular Lymphoma

Sponsor: SymBio Pharmaceuticals Limited

Chair:

Takashi Watanabe
(Department of Personalized Control Science of Myeloid and Lymphoid Tumors, Mie University Graduate School of Medicine)

Speaker:

Mathias J. Rummel
(Department for Hematology Hospital of the Justus-Liebig University Giessen, Germany)

Evening Seminar2-1

15-Oct (Sat) 18:00-18:45 No.1 Fukuoka International Congress Center 3F Main Hall

Treatment strategies for 1L DLBCL

Sponsor: Chugai Pharmaceutical Co., Ltd.

Chair:

Koji Kato
(Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science)

Speaker:

Hervé Tilly
(Department of Hematology, Centre Henri -Becquerel, Rouen, France)

Evening Seminar2-2

15-Oct (Sat) 18:00-18:45 No.2 Fukuoka International Congress Center 2F 203･204

Is it possible to separate the GVL effect from GVHD?

Sponsor: Novartis Pharma K.K.

Chair:

Satoshi Takahashi
(Division of Clinical Precision Research Platform,The Institute of Medical Science The University of Tokyo, Tokyo, Japan)

Speaker:

Yoshinobu Maeda
(Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Okayama ,Japan)

Evening Seminar2-3

15-Oct (Sat) 18:00-18:45 No.3 Fukuoka International Congress Center 2F 201･202

CAR T-cell therapy for R/R large B-cell lymphoma

Sponsor: Bristol Myers Squibb

Chair:

Akifumi Takaori-Kondo
(Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University)

Speaker:

Shinichi Makita
(National Cancer Center Hospital)

Evening Seminar2-4

15-Oct (Sat) 18:00-18:45 No.4 Fukuoka International Congress Center 4F 411･412

Current treatment strategies for peripheral T-cell lymphoma

Sponsor: Takeda Pharmaceutical Company Limited

Chair:

Kunihiro Tsukasaki
(Department of Hematology, International Medical Center, Saitama Medical University)

Speaker:

Wataru Munakata
(Department of Hematology, National Cancer Center Hospital)

Evening Seminar2-5

15-Oct (Sat) 18:00-18:45 No.5 Fukuoka International Congress Center 4F 413･414

PD-1 blockade and transplant immunology in classical Hodgkin lymphoma

Sponsor: ONO PHARMACEUTICAL CO., LTD./Bristol-Myers Squibb K.K.

Chair:

Kenichi Ishizawa
(Department of Third Internal Medicine,Yamagata University Faculty of Medicine)

Speaker:

Daigo Hashimoto
(Department of Hematology, Faculty of Medicine, Hokkaido University)

Evening Seminar2-6

15-Oct (Sat) 18:00-18:45 No.6 Fukuoka International Congress Center 4F 409･410

Updated findings in the management of TKI treatment

Sponsor: Otsuka Pharmaceutical Co., Ltd.

Chair:

Takayuki Ikezoe
(Department of Hematology, Fukushima Medical University)

Speaker:

Hirohisa Nakamae
(Hematology, Osaka Metropolitan University School of Medicine)

Evening Seminar2-7

15-Oct (Sat) 18:00-18:45 No.7 Fukuoka International Congress Center 4F 404･405･406

Systemic AL Amyloidosis -Forefront of Medical Treatment-

Sponsor: Janssen Pharmaceutical K.K.

Chair:

Ichiro Hanamura
(Division of Hematology, Department of Internal Medicine,Aichi Medical University)

Practices of AL Amyloidosis in Real World

Speaker:

Shinichi Fuchida
(Japan Community Health care Organization Kyoto Kuramaguchi Medical Center Division of Hematology)

Innovative Clinical Practice of systemic AL Amyloidosis - Importance of collaboration between Hematology and Cardiology -

Speaker:

Jin Endo
(Keio University School of Medicine Department of Cardiology)

Evening Seminar2-8

15-Oct (Sat) 18:00-18:45 No.8 Fukuoka International Congress Center 5F 501

Is the treatment of Hemophilia B the same as that of Hemophilia A? - Exploring the function of factor IX and its application to clinical practice -

Sponsor: Sanofi K.K.

Chair:

Kagehiro Amano
(Laboratory Medicine Tokyo Medical University Hospital)

Speaker:

Teruhisa Fujii
(Hemophilia Treatment Center, Division of Transfusion Medicine, Hiroshima University Hospital)

Evening Seminar2-9

15-Oct (Sat) 18:00-18:45 No.9 Fukuoka International Congress Center 5F 502

Beyond Clinical Trials: Real World Insights in Multiple Myeloma Treatment

Sponsor: Takeda Pharmaceutical Company Limited

Chair:

Yoichi Imai
(Dokkyo Medical University)

Speaker:

Hiroshi Handa
(Gunma University Graduate School of Medicine, Hematology)

Evening Seminar2-10

15-Oct (Sat) 18:00-18:45 No.10 Fukuoka International Congress Center 5F 503

Development of therapeutic strategies for CLL-Including our experiences of venetoclax treatment-

Sponsor: AbbVie GK

Chair:

Masaki Iino
(Department of Hematology, Yamanashi Prefectural Central Hospital)

Speaker:

Saburi Masuho
(Department of Hematology, Oita Prefectural Hospital)

Evening Seminar2-11

15-Oct (Sat) 18:00-18:45 No.11 Fukuoka Sunpalace 2F Palace Room AB

Detection of minimal residual disease in multiple myeloma: application for clinical care

Sponsor: Janssen Pharmaceutical K.K.

Chair:

Hiroyuki Takamatsu
(School of Entrepreneurial and Innovation Studies, Institute of Transdisciplinary Sciences, Kanazawa University)

Speaker:

Alberto Orfao
(Cancer Research Center (IBMCC-CSIC/USAL-IBSAL); Cytometry Service (NUCLEUS) and Department of Medicine, University of Salamanca, Salamanca, Spain (USAL))

Evening Seminar2-12

15-Oct (Sat) 18:00-18:45 No.12 Marine Messe Fukuoka Hall B 2F Meeting Room 1

The Evolving Treatment of Lysosomal Storage Disease - The Role of the Hematologist

Sponsor: Sanofi K.K.

Chair:

Katsuyuki Kito
(Medical Director of KITO Clinic)

Speaker:

Makoto Yoshimitsu
(Department of Hematology and Rheumatology, Graduate School of Medical and Dental Sciences, Kagoshima University)

Evening Seminar2-13

15-Oct (Sat) 18:00-18:45 No.13 Marine Messe Fukuoka Hall B 2F Meeting Room 2

Cutting-edge Cancer Immunotherapy Updates: For the Ideal Combination Immunotherapy

Sponsor: Medical Affairs Division, MSD K.K.

Chair:

Motoko Yamaguchi
(Department of Hematological Malignancies, Mie University Graduate School of Medicine)

Speaker:

Hiroyoshi Nishikawa
(Department of Immunology, Nagoya University Graduate School of Medicine Division of Cancer Immunology, Research Institute/Exploratory Oncology Research and Clinical Trial Center (EPOC), National Cancer Center)

Morning Seminar3-2

16-Oct (Sun) 8:00-8:45 No.2 Fukuoka International Congress Center 2F 203･204

New Possibilities in the Treatment of Multiple Myeloma

Sponsor: Janssen Pharmaceutical K.K.

Chair:

Takanori Teshima
(Department of Hematology, Hokkaido University Faculty of Medicine)

cilta-cel: updates and toxicity management

Speaker:

Deepu Madduri
(Janssen R&D US, /Hematology and Medical Oncology, Mount Sinai, US)

Morning Seminar3-3

16-Oct (Sun) 8:00-8:45 No.3 Fukuoka International Congress Center 2F 201･202

The future of T-cell lymphoma practice innovated by Data Science Approach

Sponsor: Eisai Co., Ltd.

Chair:

Keisuke Kataoka
(Division of Hematology, Department of Medicine, Keio University School of Medicine. )

Speaker:

Mamiko Sakata-Yanagimoto
(Department of Hematology, University of Tsukuba)

Morning Seminar3-4

16-Oct (Sun) 8:00-8:45 No.4 Fukuoka International Congress Center 4F 411･412

Diagnosis and novel treatment of immune thrombotic thrombocytopenic purpura (iTTP)-Caplacizumab, anti VWF antibody-

Sponsor: Sanofi K.K.

Chair:

Mitsuru Murata
(International University of Health and Welfare Clinical Research Center for Medicine)

Speaker:

Yoshitaka Miyakawa
(Department of Hematology, Saitama Medical University hospital)

Morning Seminar3-5

16-Oct (Sun) 8:00-8:45 No.5 Fukuoka International Congress Center 4F 413･414

Therapeutic strategy for Primary Central Nervous System Lymphoma

Sponsor: ONO PHARMACEUTICAL CO., LTD.

Chair:

Hirokazu Nagai
(Clinical Research Center National Hospital Organization Nagoya Medical Center)

Speaker:

Christian Grommes
(Memorial Sloan Kettering Cancer Center)

Morning Seminar3-6Live Recording On-demand

16-Oct (Sun) 8:00-8:45 No.6 Fukuoka International Congress Center 4F 409･410

Treatment Strategies for Aplastic Anemia Evolved by Eltrombopag

Sponsor: Novartis Pharma K.K.

Chair:

Yoshiaki Ogawa
(Division of Hematology/Oncology Department of Medicine Tokai University school of Medicine, Kanagawa, Japan)

Speaker:

Hirohito Yamazaki
(Division of Transfusion Medicine, Kanazawa University Hospital, Ishikawa, Japan)

Morning Seminar3-7

16-Oct (Sun) 8:00-8:45 No.7 Fukuoka International Congress Center 4F 404･405･406

Remaining Challenges in CML Treatment

Sponsor: Bristol Myers Squibb

Chair:

Nobuhiko Uoshima
(Department of Hematology, Japanese Red Cross, Kyoto Daini Hospital)

Speaker:

Shinya Kimura
(Division of Hematology, Respiratory Medicine and Oncology, Saga University Hospital)

Morning Seminar3-8

16-Oct (Sun) 8:00-8:45 No.8 Fukuoka International Congress Center 5F 501

Fungal infection management in Hematology Patients for the Proper Use of antifungal agents

Sponsor: Pfizer Japan Inc.

Chair:

Takehiko Mori
(Department of Hematology, Tokyo Medical and Dental University)

Diagnosis and management of fungal infections

Speaker:

Shun-ichi Kimura
(Division of Hematology, Jichi Medical University Saitama Medical Center)

Practices of Therapeutic Drug Monitoring for Antifungal Stewardship

Speaker:

Koichi Yamada
(Department of Infection Control Science,Graduate School of Medicine, Osaka Metropolitan University)

Morning Seminar3-9

16-Oct (Sun) 8:00-8:45 No.9 Fukuoka International Congress Center 5F 502

Importance of regulatory T cells in hematological malignancy

Sponsor: Meiji Seika Pharma Co., Ltd.

Chair:

Kiyohiko Hatake
(Sanno Medical Center/Department of Hematology, International University of Health and Welfare, School of Medicine)

Speaker:

Hiroyoshi Nishikawa
(Division of Cancer Immunology, Research Institute/Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center/Department of Immunology, Nagoya University Graduate School of Medicine)

Morning Seminar3-10

16-Oct (Sun) 8:00-8:45 No.10 Fukuoka International Congress Center 5F 503

Reimagine Acquired Hemophilia A Treatment -The Potential of Hemlibra-

Sponsor: Chugai Pharmaceutical Co., Ltd.

Chair:

Tadashi Matsushita
(Department of Blood Transfusion Service, Nagoya University Hospital)

Speaker:

Keiji Nogami
(Department of Pediatrics, Nara Medical University)

Morning Seminar3-12

16-Oct (Sun) 8:00-8:45 No.12 Marine Messe Fukuoka Hall B 2F Meeting Room 1

Treatment Strategies and Supportive Care for DLBCL-NEXT STEP-

Sponsor: kyowa kirin co. ltd

Chair:

Ritsuro Suzuki
(SHIMANE University, Faculty of Medicine, Department of Internal Medicine, Hematology and Oncology Division)

Treatment strategy for patients with newly diagnosed DLBCL; 2022 update

Speaker:

Nobuhiko Yamauchi
(Cancer Institute Hospital of Japanease Foundation for Cancer Research/ National Cancer Center East Hospital)

Treatment Strategies for Relapsed/Refractory DLBCL

Speaker:

Tatsu Shimoyama
(Department of Medical Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan)

Morning Seminar3-13

16-Oct (Sun) 8:00-8:45 No.13 Marine Messe Fukuoka Hall B 2F Meeting Room 2

MRD measurement in Ph+ALL and CML - Major/minor BCR-ABL

Sponsor: Otsuka Pharmaceutical Co., Ltd.

Chair:

Yuzuru Kanakura
(Sumitomo Hospital)

Clinical significance of minimal residual disease in Ph+ALL

Speaker:

Shuichi Mizuta
(Immunology and Hematology, Kanazawa Medical University)

Significance of MRD monitoring in CML

Speaker:

Naoto Takahashi
(Akita University Department of Hematology, Nephrology and Rheumatology)

Luncheon Seminar3-2

16-Oct (Sun) 12:15-13:00 No.2 Fukuoka International Congress Center 2F 203･204

Leveraging Functional Genomics to Uncover Determinants of Drug Response in AML

Sponsor: Incyte Biosciences Japan G.K.

Chair:

Koichi Akashi
(Kyushu University)

Speaker:

Jeffrey W. Tyner
(Oregon Health & Science University)

Luncheon Seminar3-3

16-Oct (Sun) 12:15-13:00 No.3 Fukuoka International Congress Center 2F 201･202

Future vision of treatment for Ph+Leukemia

Sponsor: Otsuka Pharmaceutical Co., Ltd.

Chair:

Hideki Nakasone
(Division of Hematology, Jichi Medical University Saitama Medical Center)

New Treatment Strategies for Ph-Positive Leukemia Based on TKI Treatment

Speaker:

Junichiro Yuda
(Department of Hematology and Experimental Therapeutics Office for the Promotion of Hematological Treatment Development, National Cancer Center Hospital East)

Ph+ Leukemia: 2022 Update

Speaker:

Koji Sasaki
(Department of Leukemia The University of Texas MD Anderson Cancer Center, Houston TX, U.S.A.)

Luncheon Seminar3-4

16-Oct (Sun) 12:15-13:00 No.4 Fukuoka International Congress Center 4F 411･412

DLBCL treatment in a new era

Sponsor: SymBio Pharmaceuticals Limited

Chair:

Yoshihiro Kameoka
(Department of Hematology, Nephrology and Rheumatology, Akita University Graduate School of Medicine)

Speaker:

Toru Kiguchi
(Division of Diabetes, Endocrinology and Hematology, Dokkyo Medical University Saitama Medical Center)

Luncheon Seminar3-5

16-Oct (Sun) 12:15-13:00 No.5 Fukuoka International Congress Center 4F 413･414

What has the four Sarclisa^®-based regimens changed in RRMM treatment?

Sponsor: Sanofi K.K.

Chair:

Chihiro Shimazaki
(JCHO Kyoto Kuramaguchi Medical Center)

Speaker:

Kazuhito Suzuki
(The Jikei University Kashiwa Hospital)

Speaker:

Kazutaka Sunami
(National Hospital Organization Okayama Medical Center)

Luncheon Seminar3-6Live Recording On-demand

16-Oct (Sun) 12:15-13:00 No.6 Fukuoka International Congress Center 4F 409･410

Long term management points for Japanese patients with PV

Sponsor: Novartis Pharma K.K.

Chair:

Kazuya Shimoda
(Division of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan)

Speaker:

Yoko Edahiro
(Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan)

Luncheon Seminar3-7

16-Oct (Sun) 12:15-13:00 No.7 Fukuoka International Congress Center 4F 404･405･406

Future Perspectives of Immunotherapy for B-Cell Lymphoma

Sponsor: Genmab K.K

Chair:

Kazuyuki Shimada
(Department of Hematology and Oncology, Nagoya University Gradeuate School of Medicine)

Speaker:

Momoko Nishikori
(Department of Hematology and Oncology, Gradeuate School of Medicine, Kyoto University)

Luncheon Seminar3-8

16-Oct (Sun) 12:15-13:00 No.8 Fukuoka International Congress Center 5F 501

Management of relapsed or refractory FLT3-mutated AML

Sponsor: Astellas Pharma Inc.

Chair:

Hitoshi Kiyoi
(Department of Hematology and Oncology, Nagoya University Graduate School of Medicine)

Speaker:

Catherine Smith
(Department of Medicine, Division of Hematology/Oncology, University of California San Francisco)

Luncheon Seminar3-9

16-Oct (Sun) 12:15-13:00 No.9 Fukuoka International Congress Center 5F 502

Treatment strategies for FLT3 mutated AML

Sponsor: invivoscribe / LabPMM

Chair:

Takeshi Kondo
(Aiiku Hospital, Blood Disorders Center)

Speaker:

Goichi Yoshimoto
(Saga-Ken Medical Centre Koseikan, Department of Hematology)

Luncheon Seminar3-10

16-Oct (Sun) 12:15-13:00 No.10 Fukuoka International Congress Center 5F 503

Updated ECP therapy in Japan

Sponsor: Mallinckrodt Pharmaceuticals

Chair:

Makoto Murata
(Department of Hematology, Shiga University of Medical Science)

Speaker:

Yukiyasu Ozawa
(Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital)

Luncheon Seminar3-11

16-Oct (Sun) 12:15-13:00 No.11 Fukuoka Sunpalace 2F Palace Room AB

How to set up multiple CAR-T therapies in the institute

Sponsor: Gilead Sciences K.K. Kite cell therapy/Medical Affairs

Chair:

Miki Ando
(Department of Hematology, Juntendo University School of Medicine)

Speaker:

Yasuyuki Arai
(Center for Research and Application of Cellular Therapy, Kyoto University Hospital,)

Luncheon Seminar3-12

16-Oct (Sun) 12:15-13:00 No.12 Marine Messe Fukuoka Hall B 2F Meeting Room 1

Treatment strategies for relapsed/refractory PTCL: optimal use of Darinaparsin

Sponsor: Nippon Kayaku Co.,Ltd.

Chair:

Hideaki Nakajima
(Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine)

Speaker:

Noriko Fukuhara
(Department of Hematology, Tohoku University Hospital, Sendai, Japan)

Luncheon Seminar3-13

16-Oct (Sun) 12:15-13:00 No.13 Marine Messe Fukuoka Hall B 2F Meeting Room 2

Autologous hematopoietic cell transplantation for malignant lymphoma

Sponsor: Sumitomo Pharma Co.,Ltd.

Chair:

Eisei Kondo
(Department of Hematology, Kawasaki Medical School)

Speaker:

Katsuhiro Io
(Department of Hematology, Kansai Electric Power Hospital)